Clinical Trial: Efficacy Trial of Tirzepatide in Guangxi Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Complicated with Obesity and Construction of a Therapeutic Efficacy Prediction Model (China)

China, Oct. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy Trial of Tirzepatide in Guangxi Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Complicated with Obesity and Construction of a Therapeutic Efficacy Prediction Model'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134818

Registration Time: 2026/10/21

Type: Interventional study

Primary Sponsor: Liuzhou Worker's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344132

Published by HT Digital Content Services with permission from Health Daily Digest....